Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103319374A details a high-yield asymmetric route for (S)-rivastigmine using Ellman auxiliary, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN107573304A reveals efficient Sofosbuvir intermediate synthesis reducing waste and cost for pharmaceutical supply chains globally ensuring high purity and scalability.
Patent CN102180886B details a novel enantioselective route to Galanthamine using organocatalysis, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN107312010A reveals a high-yield sitagliptin synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105732550A details a high-ee palladium-catalyzed route for chiral dihydrofurans, offering supply chain stability and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1827605A details a metal-free route to HIV drug precursors. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.
Patent CN103833560B reveals a safer Zn-catalyzed route for Efavirenz intermediates. Discover cost-effective, scalable manufacturing solutions for global supply chains.
Discover a novel Zn-catalyzed route for Efavirenz intermediates offering milder conditions, enhanced safety, and substantial cost reduction for global supply chains.
Patent CN100584459C reveals a novel metal-free organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with >99% ee, offering significant cost reduction and supply chain reliability.
Patent CN104974055B reveals high stereoselectivity synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN102627590A details a mild route to chiral alpha-tribromomethyl amines. Offers high optical purity and scalable conditions for API intermediates.
Patent CN107311911B reveals a novel chemical route for Niraparib intermediates, replacing costly enzymatic methods with scalable asymmetric synthesis for reliable supply.
Novel synthesis route for SGLT inhibitor intermediates ensures high purity and cost efficiency. Reliable supply chain partner for commercial scale pharmaceutical manufacturing.
Patent CN105330554B reveals a safer synthesis for Efavirenz intermediates. Achieve high ee values and cost reduction in API manufacturing with scalable zinc chemistry.
Novel patent CN119735538B details high-purity Brivaracetam production. This route offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturers.
Patent CN104860911B reveals a metal-free synthesis for chiral 3,4-dihydrocoumarin derivatives. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Novel asymmetric synthesis of antitumor pyrano-pyrazole derivatives via chiral phosphine catalysis. Offers high enantioselectivity and scalable routes for API intermediates.
Patent CN115403593A details a novel Ni-catalyzed [3+2] cycloaddition for chiral purine oxazoles, offering high yields and scalable routes for reliable pharmaceutical intermediate suppliers.